Join us for a timely discussion of FDA's new technical guidance on submitting clinical trial datasets to evaluate the impact of immunogenicity on drug PK. @Joleen White will provide a brief overview, followed by an interactive panel and audience Q&A featuring perspectives from the FDA publication team and the CDISC ADAADaM team.
Todd & Rob
-----
Microsoft Teams meeting
Join: https://teams.microsoft.com/meet/29478979084349?p=xfQhePEMtJeHbtRxsH
Meeting ID: 294 789 790 843 49
Passcode: Ar29fU9k
Need help? | System reference
Dial in by phone
+1 910-745-0533,,925590706# United States, Fayetteville
Find a local number
Phone conference ID: 925 590 706#
------------------------------
Todd Lester
BioAgilytix | Senior Director
Durham, NC |
[email protected]Disclaimer: Opinions expressed are solely my own and do not express the views or opinions of my employer.
------------------------------